Keeping track of these signs and speaking with a healthcare provider when they appear is important for staying safe while on testosterone therapy. This could be due to an increase in red blood cells, which thickens the blood and makes the heart pump harder. When testosterone levels rise, the body may respond by increasing its internal temperature. This can make the heart beat faster than normal, especially after taking a dose or during peak hormone levels. Testosterone is a vital hormone that plays a crucial role in men’s overall health and well-being. Similar to the previous reports, TRT resulted in a significant increase in hemoglobin levels.36 They concluded that TRT for hypogonadism does not appear to increase PSA or the risk of prostate cancer. All four studies included in this meta-analysis evaluated the effects of TRT on LVEF as well. The eligibility criteria for this meta‐analysis included all placebo‐controlled studies (randomized and nonrandomized) that enrolled men with low or low‐normal testosterone levels and who received any testosterone formulation for ≥3 months. The authors discovered a total of 14 adverse cardiovascular events in the testosterone replacement group and 7 total events in the placebo group. When analyzing the results from individual studies, it is important to consider baseline testosterone levels, the administered dose of testosterone, and finally the method of testosterone delivery. It should be noted that the majority of the studies have focused on such adverse events as cardiovascular events, prostate‐related events, and changes in red blood cell indices. In other words, testosterone replacement therapy may be causing a shift toward more type I muscle fibers in patients with CHF, thereby improving their exercise capacity while their LVEF remains the same. Testosterone supplementation resulted in a statistically significant increase in SDNN, SDANN, TP, LF, ULF, and very‑low‑frequency domain. Moreover, total power (TP) as well as high- and low‑frequency domains (HF and LF, respectively) were significantly lower in the MS+TDS+ group compared with the MS+TDS- group. Improving Cardiovascular Function Through Testosterone Replacement Therapy Testosterone replacement therapy (TRT) is a treatment option that has gained... There are several health risks with excessively high free testosterone, and I spent a few hours with a doctor friend to look at the scientific evidence for heart problems such as chronically increased heart rate. Managing the possible effects of testosterone therapy on the heart, especially an increased heart rate, requires careful planning. Basaria et al evaluated the safety and efficacy of daily application of transdermal testosterone gel in 209 men.150 Given the increased rate of adverse cardiovascular events in the testosterone group, the study was stopped prematurely. Peak VO2 and peak O2 pulse, both of which offer an accurate reflection of aerobic exercise capacity, were shown to have a positive and statistically significant association with testosterone levels in multivariable‐adjusted models.139 This indicates that the association between circulating testosterone levels and aerobic exercise capacity in CHF patients is most likely independent of heart failure severity, beta‐blocker use, and chronotropic response to exercise. Finally, Jankowska et al demonstrated that reduced levels of total and estimated free testosterone were both predictors of increased mortality in men with CHF.137 Similar findings have been reported by other investigators as well. However, none of the individual prostate-related adverse events significantly differed between groups, including incident prostate cancer, which showed no difference between the TRT group and placebo.34 In 2016, Boyle et al. reported results of a meta-analysis on prostate cancer in TRT trials. The TRT group had a significantly greater incidence of all prostate-related adverse events, with a pooled odds ratio of 1.78 (95% CI, 1.07–2.95). In this study, fat biopsies were also used to show that the expression of insulin-signaling genes (IR-ß, IRS-1, AKT-2, and GLUT 4) was lower in men with TD and diabetes. Of the patients in the TRT group, 35% (20 of 57) experienced an improvement of ≥ 1 NYHA class in their functional capacity compared to only 9.8% of patients in the placebo group (5 of 51). Although T was shown to significantly improve exercise capacity, none of the studies found a significant change in LVEF, although NYHA class was shown to improve in two of the studies. The effect of testosterone on these parameters in various populations has been the subject of debate in many meta-analyses.71 However, due to the nature of the studies, reverse causality cannot be ruled out. Nettleship et al.65 found that testosterone slows atheroma development and reverses lipid deposition in the artery wall. It is believed that this process involves the downregulation of L-type voltage-gated calcium channels61 and upregulation of calcium-activated potassium channels.62 The immediacy of the vasodilation has raised questions as to whether the underlying mechanism involves non-genomic actions of testosterone. BMI, body mass index; Ca, calcium; H, hydrogen; HbA1c, hemoglobin A1c; hs-CRP, high-sensitivity C-reactive protein; K, potassium; O, oxygen; OH, hydroxide; QTc interval, heart-rate–corrected QT interval. A key pathologic feature of congestive heart failure (CHF) is a metabolic shift toward catabolism, which results from the activation of neuroendocrine and inflammatory pathways.135–136 This imbalance, in turn, causes progressively worsening exercise intolerance, as well as cardiac cachexia.135–136 Emerging evidence indicates that there might be a significant association between testosterone deficiency, CHF, and exercise capacity. Furthermore, the exact mechanism by which testosterone may cause increased IMT of the carotid artery or the aorta is currently unknown. On the other hand, it can be argued that widespread atherosclerosis may impair adequate blood flow to the testes or to the pituitary gland, which would in turn result in decreased production of testosterone and luteinizing hormone, respectively. When the heart beats faster than this without a clear reason, it may signal a problem. One possible side effect that some people may notice is a faster heartbeat. But like any medication, TRT can also cause side effects. While this does not happen in every patient, it may explain why some people feel jittery or experience palpitations after starting therapy. Some studies also suggest that TRT may stimulate the sympathetic nervous system. The researchers did not find a strong link between TRT and serious heart rhythm problems like atrial fibrillation or sudden tachycardia. Still, the overall number was low, and most men did not show signs of serious heart problems.
